Loading insider details...
Beta
Latest Form 4 (Sep 8, 2026): Purchase of 89,200 EIKN shares, $1.03M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 8, 2026 | Eikon Therapeutics, Inc. (EIKN) | Purchase | 89,200 | $1.03M |
| Feb 10, 2026 | Eikon Therapeutics, Inc. (EIKN) | Conversion | 1,296,629 | n/a |
| Dec 23, 2024 | RAPT Therapeutics, Inc. (RAPT) | Other (see footnotes) | 1,352,008 | n/a |
| Apr 8, 2024 | NGM BIOPHARMACEUTICALS INC (NGM) | Disposition to Issuer | 949,862 | n/a |
| May 27, 2022 | RAPT Therapeutics, Inc. (RAPT) | Purchase | 1,837 | $22.9K |
| May 25, 2022 | RAPT Therapeutics, Inc. (RAPT) | Purchase | 9,898 | $123.7K |
| May 12, 2022 | RAPT Therapeutics, Inc. (RAPT) | Purchase | 1,208,750 | $12.90M |